Full Text View
Tabular View
No Study Results Posted
Related Studies
The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor.
This study is currently recruiting participants.
Study NCT00404768   Information provided by GlaxoSmithKline
First Received: November 27, 2006   Last Updated: October 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Premature Labor
Additional conditions recognized in this trial
Obstetric Labor, Premature
More general conditions related to this trial
Obstetric Labor Complications
Pregnancy Complications
Interventions listed in this trial
Placebo
GSK221149A
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services